Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2025-12-26 @ 12:16 PM
NCT ID:
NCT02408900
Eligibility Criteria:
* INCLUSION CRITERIA:\<TAB\>
Healthy Controls
* Adults between ages of 18-75; matched to the patient cohort
* No history of neurological disorder
* No use of medications that produce muscle relaxation within 1 week of study, such as baclofen, cyclobenzaprine, or tizanidine.
* Able to give informed consent
Patients
* Adults between ages of 18-75
* A clinical diagnosis of primary lateral sclerosis determined in NIH protocol 01-N-0145.
* No contractures of arms and legs
* Able to give informed consent
EXCLUSION CRITERIA:
* Mechanical limitation of elbow flexion
* Achilles tendon surgical procedures
* History of cervical radiculopathy
* History of botulinum injections
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02408900
Study Brief:
Protocol Section:
NCT02408900